Focus Partners Wealth grew its stake in Oracle Co. (NYSE:ORCL - Free Report) by 10.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 317,096 shares of the enterprise software provider's stock after acquiring an additional 30,091 shares during the period. Focus Partners Wealth's holdings in Oracle were worth $54,368,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the stock. Norges Bank acquired a new stake in Oracle in the 4th quarter valued at about $2,216,314,000. Raymond James Financial Inc. acquired a new stake in Oracle during the fourth quarter worth approximately $930,095,000. Vanguard Group Inc. lifted its position in Oracle by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock worth $26,231,127,000 after acquiring an additional 2,296,069 shares during the last quarter. Kovitz Investment Group Partners LLC lifted its position in Oracle by 268.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider's stock worth $512,909,000 after acquiring an additional 2,242,520 shares during the last quarter. Finally, Northern Trust Corp lifted its position in Oracle by 12.5% during the fourth quarter. Northern Trust Corp now owns 19,620,534 shares of the enterprise software provider's stock worth $3,269,566,000 after acquiring an additional 2,176,892 shares during the last quarter. Institutional investors own 42.44% of the company's stock.
Insider Buying and Selling at Oracle
In other Oracle news, Director Naomi O. Seligman sold 2,866 shares of the business's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the sale, the director now directly owns 31,764 shares in the company, valued at $4,749,670.92. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Leon E. Panetta sold 17,500 shares of the company's stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the transaction, the director now directly owns 58,090 shares in the company, valued at $8,785,531.60. This represents a 23.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,366 shares of company stock worth $4,015,723 over the last three months. 42.20% of the stock is currently owned by insiders.
Analysts Set New Price Targets
ORCL has been the subject of several research reports. Stephens initiated coverage on shares of Oracle in a research report on Wednesday, March 19th. They set an "equal weight" rating and a $167.00 price objective for the company. Guggenheim restated a "buy" rating and set a $220.00 price objective on shares of Oracle in a research report on Thursday, April 3rd. Cantor Fitzgerald cut their price objective on shares of Oracle from $214.00 to $175.00 and set an "overweight" rating for the company in a research report on Tuesday, March 11th. JMP Securities reiterated a "market outperform" rating and issued a $205.00 price target on shares of Oracle in a research report on Wednesday, January 22nd. Finally, Mizuho dropped their price target on shares of Oracle from $210.00 to $180.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Fourteen research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Oracle presently has a consensus rating of "Moderate Buy" and a consensus target price of $174.42.
View Our Latest Research Report on ORCL
Oracle Stock Down 0.1%
Shares of NYSE:ORCL traded down $0.19 during midday trading on Wednesday, hitting $162.09. 1,556,164 shares of the company's stock were exchanged, compared to its average volume of 9,449,612. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81. The stock has a 50 day moving average price of $142.26 and a 200-day moving average price of $162.76. The company has a market cap of $453.34 billion, a PE ratio of 39.65, a price-to-earnings-growth ratio of 3.46 and a beta of 1.27. Oracle Co. has a 12 month low of $114.55 and a 12 month high of $198.31.
Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.02). The firm had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. Oracle's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.41 EPS. On average, sell-side analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.
Oracle Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend was Thursday, April 10th. This is an increase from Oracle's previous quarterly dividend of $0.40. Oracle's dividend payout ratio (DPR) is 46.95%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report